COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Sellersville

Our Sellersville, USA facility is a USFDA inspected and EMA certified, fully integrated site which offers product and process development, clinical supply and commercial manufacturing and packaging of solid oral dosage forms, liquids, creams, and ointments.

Location Address:

Piramal Pharma Solutions, 650 Cathill Rd, Sellersville, PA 18960, USA

Contact: +1 215-799-5000

Site capabilities

  • Dose form technologies handled at the site
    • Immediate release capsules & tablets
    • Modified release capsules & tablets
    • Orally disintegrating tablets
    • Sublingual tablets
    • Oral liquids (Solutions & Suspensions)
    • Controlled substance dosage forms
  • Liquid, cream and ointment dosage forms with a maximum capacity of 350, 150 and 100 batches
  • Liquid production
    • 8 manufacturing suites
    • Potent suite – 2 rooms, Fumes exhaust to the outside, Haz. Category IV
  • Cream and ointment production
    • 9 manufacturing suites
  • Serialized packaging
    • Three solid dose packaging lines
    • Serialized finished goods – individual unit and aggregation
  • Four non serialized LCO packaging lines for liquids, creams and ointments
  • Key warehouse capabilities
    • 2,800 pallet location storage
    • DEA cage area (Class III-Class V)
    • 1,260 sq. ft. refrigerated storage unit

Specialized capabilities

  • High shear granulators, V-blenders and bin technologies for manufacturing OSDs
  • Roller compaction technology, hot melt granulation, fluid bed technologies and low humidity process suites
  • Temperature controlled warehousing
  • Quality control microbiology laboratory

Featured Services

  • Ability to handle high potent formulations and controlled substance
  • Product development and manufacturing – OSDs, liquids, creams and ointments
  • Serialized packaging of OSDs
  • Packaging of liquids, creams and ointments
  • Warehousing of the final dosage forms

Salient Features

  • Inspected by global regulatory bodies like USFDA and ANSM (EMA)
  • 40+ years of experience in product development and manufacturing
Virtual Tour
Take a video tour of our Sellersville plant